Limbaroc, Rhea .
HRN: 23-95-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2023
CEFTRIAXONE 1G (VIAL)
10/27/2023
11/03/2023
IV DRIP
1.5g
Q12
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes